New fabry drug shows promise in small switch study
NCT ID NCT05843916
First seen Feb 25, 2026 · Last updated May 15, 2026 · Updated 12 times
Summary
This study tested a new, similar version of the drug agalsidase beta (called AGA BETA BS) in 20 people with Fabry disease who were already doing well on the standard drug Fabrazyme. The goal was to see if switching to the new drug kept their disease marker (Lyso-Gb3) at the same low level after 6 months. The study was completed and compared the new drug's safety and effectiveness to the standard treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FABRY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centro Médico Santa María de la Salud
San Isidro, Buenos Aires, 1642, Argentina
-
Centro Oncológico Riojano Integral
La Rioja, F5300, Argentina
-
Clínica Universitaria Reina Fabiola
Córdoba, X5004, Argentina
-
Instituto de Investigaciones Clínicas Quilmes
Buenos Aires, Argentina
-
Instituto de Nefrología Pergamino S.R.L
Pergamino, Buenos Aires, 2700, Argentina
Conditions
Explore the condition pages connected to this study.